Motor responses of autoimmune NZB/B1NJ and C57BL/6Nnia mice to arecoline and nicotine

Konrad C. Retz, Clayton K. Trimmer, Michael J. Forster, Harbans Lal

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In 11-13 month C57BL/6Nnia mice, arecoline produced a dose-dependent decrease in motor activity at doses of 0.64-2.5 mg/kg, whereas at doses of 5.0-20.0 mg/kg arecoline produced a dose-dependent increase in motor activity. In marked contrast, age-matched NZB/B1NJ (New Zealand Black) mice failed to exhibit the first phase of the response, but showed a greater dose-dependent increase in motor activity following the doses of 10 and 20 mg/kg. Nicotine, 0.64-2.5 mg/kg, produced a dose-dependent decrease in motor activity in both strains. The effects of arecoline and nicotine were antagonized by scopolamine (2.5 mg/kg) and mecamylamine (1.0 mg/kg), respectively. These findings suggest that muscarinic neurotransmission may be altered in NZB/B1NJ mice, which produce brain-reactive autoantibodies, exhibit learning/memory dysfunctions, and also exhibit a loss of neurons staining positive for choline acetyltransferase.

Original languageEnglish (US)
Pages (from-to)275-282
Number of pages8
JournalPharmacology, Biochemistry and Behavior
Volume28
Issue number2
DOIs
StatePublished - 1987

Fingerprint

Arecoline
Autoimmunity
Nicotine
Inbred C57BL Mouse
Motor Activity
Inbred NZB Mouse
Mecamylamine
Scopolamine Hydrobromide
Choline O-Acetyltransferase
New Zealand
Synaptic Transmission
Autoantibodies
Cholinergic Agents
Neurons
Brain
Learning
Staining and Labeling
Data storage equipment

Keywords

  • Arecoline
  • Autoimmunity
  • C57BL/6Nnia mice
  • Mecamylamine
  • Motor activity
  • Nicotine
  • NZB/B1NJ mice
  • Scopolamine

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Motor responses of autoimmune NZB/B1NJ and C57BL/6Nnia mice to arecoline and nicotine. / Retz, Konrad C.; Trimmer, Clayton K.; Forster, Michael J.; Lal, Harbans.

In: Pharmacology, Biochemistry and Behavior, Vol. 28, No. 2, 1987, p. 275-282.

Research output: Contribution to journalArticle

Retz, Konrad C. ; Trimmer, Clayton K. ; Forster, Michael J. ; Lal, Harbans. / Motor responses of autoimmune NZB/B1NJ and C57BL/6Nnia mice to arecoline and nicotine. In: Pharmacology, Biochemistry and Behavior. 1987 ; Vol. 28, No. 2. pp. 275-282.
@article{6ce9ad1f96cc4ef6ac52e013ac243a40,
title = "Motor responses of autoimmune NZB/B1NJ and C57BL/6Nnia mice to arecoline and nicotine",
abstract = "In 11-13 month C57BL/6Nnia mice, arecoline produced a dose-dependent decrease in motor activity at doses of 0.64-2.5 mg/kg, whereas at doses of 5.0-20.0 mg/kg arecoline produced a dose-dependent increase in motor activity. In marked contrast, age-matched NZB/B1NJ (New Zealand Black) mice failed to exhibit the first phase of the response, but showed a greater dose-dependent increase in motor activity following the doses of 10 and 20 mg/kg. Nicotine, 0.64-2.5 mg/kg, produced a dose-dependent decrease in motor activity in both strains. The effects of arecoline and nicotine were antagonized by scopolamine (2.5 mg/kg) and mecamylamine (1.0 mg/kg), respectively. These findings suggest that muscarinic neurotransmission may be altered in NZB/B1NJ mice, which produce brain-reactive autoantibodies, exhibit learning/memory dysfunctions, and also exhibit a loss of neurons staining positive for choline acetyltransferase.",
keywords = "Arecoline, Autoimmunity, C57BL/6Nnia mice, Mecamylamine, Motor activity, Nicotine, NZB/B1NJ mice, Scopolamine",
author = "Retz, {Konrad C.} and Trimmer, {Clayton K.} and Forster, {Michael J.} and Harbans Lal",
year = "1987",
doi = "10.1016/0091-3057(87)90225-5",
language = "English (US)",
volume = "28",
pages = "275--282",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Motor responses of autoimmune NZB/B1NJ and C57BL/6Nnia mice to arecoline and nicotine

AU - Retz, Konrad C.

AU - Trimmer, Clayton K.

AU - Forster, Michael J.

AU - Lal, Harbans

PY - 1987

Y1 - 1987

N2 - In 11-13 month C57BL/6Nnia mice, arecoline produced a dose-dependent decrease in motor activity at doses of 0.64-2.5 mg/kg, whereas at doses of 5.0-20.0 mg/kg arecoline produced a dose-dependent increase in motor activity. In marked contrast, age-matched NZB/B1NJ (New Zealand Black) mice failed to exhibit the first phase of the response, but showed a greater dose-dependent increase in motor activity following the doses of 10 and 20 mg/kg. Nicotine, 0.64-2.5 mg/kg, produced a dose-dependent decrease in motor activity in both strains. The effects of arecoline and nicotine were antagonized by scopolamine (2.5 mg/kg) and mecamylamine (1.0 mg/kg), respectively. These findings suggest that muscarinic neurotransmission may be altered in NZB/B1NJ mice, which produce brain-reactive autoantibodies, exhibit learning/memory dysfunctions, and also exhibit a loss of neurons staining positive for choline acetyltransferase.

AB - In 11-13 month C57BL/6Nnia mice, arecoline produced a dose-dependent decrease in motor activity at doses of 0.64-2.5 mg/kg, whereas at doses of 5.0-20.0 mg/kg arecoline produced a dose-dependent increase in motor activity. In marked contrast, age-matched NZB/B1NJ (New Zealand Black) mice failed to exhibit the first phase of the response, but showed a greater dose-dependent increase in motor activity following the doses of 10 and 20 mg/kg. Nicotine, 0.64-2.5 mg/kg, produced a dose-dependent decrease in motor activity in both strains. The effects of arecoline and nicotine were antagonized by scopolamine (2.5 mg/kg) and mecamylamine (1.0 mg/kg), respectively. These findings suggest that muscarinic neurotransmission may be altered in NZB/B1NJ mice, which produce brain-reactive autoantibodies, exhibit learning/memory dysfunctions, and also exhibit a loss of neurons staining positive for choline acetyltransferase.

KW - Arecoline

KW - Autoimmunity

KW - C57BL/6Nnia mice

KW - Mecamylamine

KW - Motor activity

KW - Nicotine

KW - NZB/B1NJ mice

KW - Scopolamine

UR - http://www.scopus.com/inward/record.url?scp=0023618748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023618748&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(87)90225-5

DO - 10.1016/0091-3057(87)90225-5

M3 - Article

C2 - 3685061

AN - SCOPUS:0023618748

VL - 28

SP - 275

EP - 282

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 2

ER -